Study of NTBC for Tyrosinemia I

计划入组 20 人 · 首次发布于 1999 年 10 月 19 日

Hereditary Hepatorenal Tyrosinemia Natural History in Egypt and the Arab World (Multicenter Clinical Study)

计划入组 50 人 · 首次发布于 2018 年 2 月 27 日

Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin)

首次发布于 2017 年 9 月 15 日

FAH gene therapy (lentiviral vector, tyrosinemia type I )

Nitisinone(Nityr, Orfadin)

C₁₄H₁₀F₃NO₅ · Rx

In Utero Gene Therapy Approaches First FDA Trial After 25 Years of Development

Nitisinone Shows Promise as Novel Malaria Control Strategy by Making Human Blood Lethal to Mosquitoes

BioCryst Pharmaceuticals Divests European ORLADEYO Rights for $264 Million to Achieve Debt-Free Status